Alerts will be sent to your verified email
Verify Email
TORNTPHARM
|
Torrent Pharma
|
Cipla
|
Dr. Reddy's Lab
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
20.79 % | 13.9 % | 15.68 % |
|
5yr Avg Net Profit Margin
|
13.95 % | 14.31 % | 15.18 % |
|
Price to Book
|
15.97 | 4.11 | 3.18 |
|
P/E
|
60.55 | 23.78 | 18.81 |
|
5yr Avg Cash Conversion Cycle
|
-186.79 Days | -4.31 Days | 74.48 Days |
|
5yr Average Interest Coverage Ratio
|
7.38 | 53.73 | 35.66 |
|
5yr Avg ROCE
|
25.78 % | 19.36 % | 21.82 % |
|
5yr Avg Operating Profit Margin
|
30.49 % | 23.02 % | 23.61 % |
|
5 yr average Debt to Equity
|
0.66 | 0.03 | 0.12 |
|
5yr CAGR Net Profit
|
8.83 % | 17.0 % | 23.71 % |
|
5yr Average Return on Assets
|
9.73 % | 11.19 % | 11.24 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
68.31 % | 29.19 % | 26.64 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-2.94 % | -4.42 % | -0.07 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-2.83 % | 7.05 % | -0.6 % |
|
Torrent Pharma
|
Cipla
|
Dr. Reddy's Lab
|
|---|